Matthew Bick
CEO and co-founder at Accipiter Biosciences
Matthew Bick is CEO and co-founder at Accipiter Biosciences, a biotechnology startup. He has over 20 years of expertise in leadership and research within therapeutics design, computational protein engineering, and structural biology.
-
Accipiter Biosciences CEO and co-founder 2023–present, CSO 2023 · current
-
Accipiter Bio Co-founder and CEO · current
-
Aquinox Pharmaceuticals Senior Director of Protein Sciences 2023, Director of Protein Sciences 2021–2023, Principal Scientist 2020–2021 · past
-
Lyell Immunopharma Senior Scientist / Project Lead 2019–2020 · past
-
Avatar Biotechnologies Independent Consultant 2011 · past
-
University of Washington Senior Fellow 2011–2018 · past
-
Ascent Biomedical Ventures Intern 2010–2011 · past
-
The Rockefeller University Postdoctoral Associate 2010–2011, Graduate Fellow 2003–2010, Research Assistant 2000–2002 · past
-
Berhard Nocht Institute for Tropical Medicine, Hamburg German Research Assistant 2003 · past
-
University of Cape Town Summer Undergraduate Research Intern 1999 · past
-
University of Rochester Undergraduate Independent Study 1997–1999 · past
Education
-
The Rockefeller University PhD, Biophysics · 2003–2010
-
University of Rochester BS, Microbiology · 1995–2000
-
University of North Carolina School of the Arts High School Diploma, Classical Guitar Performance, Composition · 1991–1995
Organizations
See all 11-
Accipiter Biosciences CEO and co-founder 2023–present, CSO 2023 · current
-
Accipiter Bio Co-founder and CEO · current
-
Aquinox Pharmaceuticals Senior Director of Protein Sciences 2023, Director of Protein Sciences 2021–2023, Principal Scientist 2020–2021 · past
Education
-
The Rockefeller University PhD, Biophysics · 2003–2010
-
University of Rochester BS, Microbiology · 1995–2000
-
University of North Carolina School of the Arts High School Diploma, Classical Guitar Performance, Composition · 1991–1995
